INN: Buprenorphine
Presentation: solution for injections 0.3 mg/ml, 1 ml ampoules 10 units per pack, 1 ml single-dose syringes N 20, N 50, N 100.
Included in the List of narcotic drugs and psychotropic substances which circulation in the Russian Federation is restricted and in which respect control measures shall be established in accordance with the legislation of the Russian Federation and the international treaties of the Russian Federation (List II)
Registration number: R N002817/01
By prescription
Pharmacotherapeutic group: analgesic narcotic drug opioid agonist-antagonist.
Indications for use:
- analgesic agent for treatment of severe pain syndrome caused by injuries, burns, in the preoperational, operational and postoperative periods, in treatment of myocardial infarction, acute angina, oncological pains and other medical conditions accompanied by pain.
Shelf life: (ampoules) 4 years
(single-dose syringes) 2 years